From September 13-14, Clinical Operations Series: Rare Disease Select will bring together senior leaders across the pharmaceutical and biotech fields to provide practical insight on how outsourcing, decentralized trial strategies, patient-centric design and digital transformation can address complexities and execute cost efficient clinical trials on time and on budget.

• By Invite Only: Participation is strictly limited to 30 executives from leading corporations to facilitate true peer-level networking
• Closed Door Meeting: Discussions aren't recorded or shared
• Strategic Content: The intellectual content of the conference program is specifically designed for the seniority and maturity of the participants
• Tailored Itinerary: Only attend the topics and meet the peers aligned with your current business objectives

To learn more, download the agenda or email enquiry@unitelifesciences.com.